LULICONAZOLE

LULICONAZOLE was reported 176 times

These side effects are most commonly reported by patients taking LULICONAZOLE:

# Side effect Count
0 DRUG INEFFECTIVE 12
1 HEPATIC FUNCTION ABNORMAL 9
2 NAUSEA 9
3 CONSTIPATION 8
4 PYREXIA 8
5 DECREASED APPETITE 7
6 OFF LABEL USE 7
7 DIARRHOEA 6
8 PNEUMONIA 6
9 ANAEMIA 5
10 ANXIETY 5
11 ERYTHEMA 5
12 SLEEP DISORDER 5
13 ACUTE KIDNEY INJURY 4
14 ALANINE AMINOTRANSFERASE INCREASED 4
15 BLISTER 4
16 BLOOD PRESSURE INCREASED 4
17 CELLULITIS 4
18 CEREBRAL HAEMORRHAGE 4
19 CONDITION AGGRAVATED 4
20 DEHYDRATION 4
21 FALL 4
22 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4
23 INFECTION 4
24 INSOMNIA 4
25 INTERSTITIAL LUNG DISEASE 4
26 MALAISE 4
27 NEUROPATHY PERIPHERAL 4
28 NO ADVERSE EVENT 4
29 PERIPHERAL SWELLING 4
30 PRURITUS 4
31 URINARY TRACT INFECTION 4
32 ABDOMINAL PAIN 3
33 ABDOMINAL PAIN UPPER 3
34 CARDIAC FAILURE 3
35 DIZZINESS 3
36 DRUG INTOLERANCE 3
37 DRY SKIN 3
38 EYE DISORDER 3
39 FEBRILE NEUTROPENIA 3
40 GASTROOESOPHAGEAL REFLUX DISEASE 3
41 HYPERGLYCAEMIA 3
42 LEUKOPENIA 3
43 MUSCULOSKELETAL STIFFNESS 3
44 NEUTROPENIA 3
45 OSTEOPOROSIS 3
46 PNEUMOCYSTIS JIROVECII PNEUMONIA 3
47 PRODUCT USE ISSUE 3
48 RASH 3
49 RENAL FAILURE 3
50 SEPSIS 3
51 SKIN DISORDER 3
52 SKIN IRRITATION 3
53 SPINAL COMPRESSION FRACTURE 3
54 THROMBOCYTOPENIA 3
55 TINEA PEDIS 3
56 WEIGHT INCREASED 3
57 ABDOMINAL DISCOMFORT 2
58 ABNORMAL FAECES 2
59 APPLICATION SITE BURN 2
60 APPLICATION SITE PAIN 2
61 APPLICATION SITE RASH 2
62 ASPARTATE AMINOTRANSFERASE INCREASED 2
63 BACK PAIN 2
64 BACTERAEMIA 2
65 BLOOD CREATININE INCREASED 2
66 BLOOD URINE PRESENT 2
67 BRONCHITIS 2
68 C-REACTIVE PROTEIN INCREASED 2
69 CATARACT 2
70 CEREBRAL INFARCTION 2
71 CHOKING 2
72 CHOLANGITIS 2
73 CHRONIC KIDNEY DISEASE 2
74 COLON CANCER 2
75 CONTUSION 2
76 CORONAVIRUS TEST POSITIVE 2
77 COVID-19 2
78 COVID-19 PNEUMONIA 2
79 DEPRESSIVE SYMPTOM 2
80 DIABETIC NEPHROPATHY 2
81 DISCOMFORT 2
82 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2
83 DRUG ERUPTION 2
84 DRUG INTERACTION 2
85 DYSARTHRIA 2
86 DYSPEPSIA 2
87 DYSPHAGIA 2
88 DYSPNOEA 2
89 END STAGE RENAL DISEASE 2
90 EXPIRED PRODUCT ADMINISTERED 2
91 FATIGUE 2
92 FULMINANT TYPE 1 DIABETES MELLITUS 2
93 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2
94 GASTROINTESTINAL DISORDER 2
95 HEADACHE 2
96 HEPATITIS C 2
97 HERPES ZOSTER 2
98 HYPERURICAEMIA 2
99 HYPOAESTHESIA 2
100 HYPOGAMMAGLOBULINAEMIA 2
101 HYPONATRAEMIA 2
102 INFUSION RELATED REACTION 2
103 LOSS OF CONSCIOUSNESS 2
104 MALIGNANT MELANOMA 2
105 MIGRAINE 2
106 MUSCLE SPASMS 2
107 MYCOBACTERIUM AVIUM COMPLEX IMMUNE RESTORATION DISEASE 2
108 NAIL DISCOLOURATION 2
109 NECROTISING RETINITIS 2
110 NEUTROPHIL COUNT DECREASED 2
111 OEDEMA PERIPHERAL 2
112 OESOPHAGEAL ATONY 2
113 PAIN 2
114 PATIENT DISSATISFACTION WITH TREATMENT 2
115 PLANTAR FASCIITIS 2
116 PLATELET COUNT DECREASED 2
117 PLEURAL EFFUSION 2
118 PNEUMONITIS 2
119 PRODUCT USE IN UNAPPROVED INDICATION 2
120 PULMONARY TOXICITY 2
121 RENAL IMPAIRMENT 2
122 STOMATITIS 2
123 THERAPY INTERRUPTED 2
124 TINEA INFECTION 2
125 TUBULOINTERSTITIAL NEPHRITIS 2
126 VISUAL IMPAIRMENT 2
127 VOMITING 2
128 WEIGHT DECREASED 2
129 ABDOMINAL DISTENSION 1
130 ABSCESS 1
131 ACCIDENTAL EXPOSURE TO PRODUCT 1
132 ACNE 1
133 ACUTE MYOCARDIAL INFARCTION 1
134 ACUTE RESPIRATORY FAILURE 1
135 ADVERSE REACTION 1
136 AMOEBIC COLITIS 1
137 ANAL FISTULA 1
138 ANAPHYLACTIC REACTION 1
139 ANHEDONIA 1
140 ANIMAL BITE 1
141 ANTI-INSULIN ANTIBODY POSITIVE 1
142 AORTIC DISSECTION 1
143 APLASTIC ANAEMIA 1
144 APPLICATION SITE CELLULITIS 1
145 APPLICATION SITE EROSION 1
146 APPLICATION SITE PURPURA 1
147 APPLICATION SITE SWELLING 1
148 ARTERIOSCLEROSIS CORONARY ARTERY 1
149 ASCITES 1
150 ATRIAL FIBRILLATION 1
151 AUTOIMMUNE HEPATITIS 1
152 BALANCE DISORDER 1
153 BASOSQUAMOUS CARCINOMA 1
154 BLADDER CANCER 1
155 BLADDER DISORDER 1
156 BLOOD ALBUMIN DECREASED 1
157 BLOOD ALKALINE PHOSPHATASE INCREASED 1
158 BLOOD CREATINE PHOSPHOKINASE INCREASED 1
159 BLOOD LACTATE DEHYDROGENASE INCREASED 1
160 BLOOD POTASSIUM INCREASED 1
161 BLOOD PRESSURE DECREASED 1
162 BLOOD UREA INCREASED 1
163 BODY TINEA 1
164 BONE DENSITY DECREASED 1
165 BONE MARROW FAILURE 1
166 BRAIN OEDEMA 1
167 BRONCHIECTASIS 1
168 BRONCHOSPASM 1
169 BURNING SENSATION 1
170 BURSITIS INFECTIVE 1
171 CARCINOEMBRYONIC ANTIGEN INCREASED 1
172 CARPAL TUNNEL SYNDROME 1
173 CEREBELLAR HAEMORRHAGE 1
174 CHEST DISCOMFORT 1
175 CHILLS 1
176 CHOLELITHIASIS 1
177 CLOSTRIDIUM DIFFICILE COLITIS 1
178 COLITIS 1
179 COLITIS ULCERATIVE 1
180 COLONIC POLYP 1
181 CONJUNCTIVITIS 1
182 COUGH 1
183 CREATINE KINASE INCREASED 1
184 CROHN^S DISEASE 1
185 CUTANEOUS SYMPTOM 1
186 CYTOMEGALOVIRUS TEST POSITIVE 1
187 DEATH 1
188 DEPRESSED MOOD 1
189 DERMATITIS 1
190 DERMATITIS CONTACT 1
191 DIABETIC NEUROPATHY 1
192 DISEASE RECURRENCE 1
193 DIVERTICULITIS 1
194 DRUG DOSE OMISSION 1
195 DRUG HYPERSENSITIVITY 1
196 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
197 DRUG PRESCRIBING ERROR 1
198 DRUG RESISTANCE 1
199 DRUG-INDUCED LIVER INJURY 1
200 DRY EYE 1
201 DYSLALIA 1
202 DYSPHONIA 1
203 EMOTIONAL DISORDER 1
204 EMOTIONAL DISTRESS 1
205 ENANTHEMA 1
206 ENCEPHALOPATHY 1
207 EOSINOPHIL COUNT INCREASED 1
208 EOSINOPHIL PERCENTAGE INCREASED 1
209 EOSINOPHILIA 1
210 EOSINOPHILIC PNEUMONIA ACUTE 1
211 EPIGLOTTITIS 1
212 EPISTAXIS 1
213 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1
214 ERECTILE DYSFUNCTION 1
215 ERYTHEMA MULTIFORME 1
216 EXPOSURE DURING PREGNANCY 1
217 EYELID INFECTION 1
218 FOLLICULITIS 1
219 GAIT DISTURBANCE 1
220 GASTRIC CANCER 1
221 GASTRIC POLYPS 1
222 GASTRIC ULCER 1
223 GENERAL PHYSICAL HEALTH DETERIORATION 1
224 GOUT 1
225 HAEMARTHROSIS 1
226 HAEMATOMA 1
227 HAEMATURIA 1
228 HAEMOGLOBIN DECREASED 1
229 HAEMOPHILIC ARTHROPATHY 1
230 HAEMORRHAGE 1
231 HAEMORRHAGE INTRACRANIAL 1
232 HAEMORRHAGIC CEREBRAL INFARCTION 1
233 HALLUCINATION, VISUAL 1
234 HEPATIC CONGESTION 1
235 HEPATIC ENZYME INCREASED 1
236 HIATUS HERNIA 1
237 HYDROCEPHALUS 1
238 HYPERBILIRUBINAEMIA 1
239 HYPERKALAEMIA 1
240 HYPERSENSITIVITY 1
241 HYPERTENSION 1
242 HYPERTRIGLYCERIDAEMIA 1
243 HYPOALBUMINAEMIA 1
244 HYPOGLYCAEMIA 1
245 HYPOPHAGIA 1
246 HYPOPROTEINAEMIA 1
247 HYPOTENSION 1
248 ILEUS 1
249 IMMUNE-MEDIATED ENTEROCOLITIS 1
250 IMMUNE-MEDIATED HYPOTHYROIDISM 1
251 IMMUNODEFICIENCY 1
252 INCOHERENT 1
253 INCREASED UPPER AIRWAY SECRETION 1
254 INFECTED DERMAL CYST 1
255 INFLUENZA 1
256 INFLUENZA LIKE ILLNESS 1
257 INJECTION SITE PAIN 1
258 INSURANCE ISSUE 1
259 INTENTIONAL PRODUCT USE ISSUE 1
260 INTERLEUKIN-2 RECEPTOR INCREASED 1
261 INTERMENSTRUAL BLEEDING 1
262 INTERNATIONAL NORMALISED RATIO ABNORMAL 1
263 JOINT INJURY 1
264 KIDNEY FIBROSIS 1
265 KL-6 INCREASED 1
266 LACUNAR INFARCTION 1
267 LARGE INTESTINAL STENOSIS 1
268 LEUKAEMIA 1
269 LIP EROSION 1
270 LIP SWELLING 1
271 LIVER FUNCTION TEST ABNORMAL 1
272 LUNG ADENOCARCINOMA 1
273 LUNG OPACITY 1
274 LUPUS-LIKE SYNDROME 1
275 LYMPHOCYTE COUNT DECREASED 1
276 LYMPHOCYTE MORPHOLOGY ABNORMAL 1
277 MALIGNANT MELANOMA IN SITU 1
278 MANIA 1
279 MEDICAL DEVICE SITE BURN 1
280 MENISCUS INJURY 1
281 METABOLIC ACIDOSIS 1
282 METASTASES TO CENTRAL NERVOUS SYSTEM 1
283 METASTASES TO THORAX 1
284 MOBILITY DECREASED 1
285 MONOCYTE COUNT INCREASED 1
286 MUCOCUTANEOUS CANDIDIASIS 1
287 MULTIPLE FRACTURES 1
288 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1
289 MULTIPLE SCLEROSIS RELAPSE 1
290 MULTIPLE-DRUG RESISTANCE 1
291 MYASTHENIA GRAVIS 1
292 MYELODYSPLASTIC SYNDROME TRANSFORMATION 1
293 NAIL DISORDER 1
294 NAIL GROWTH ABNORMAL 1
295 NAIL INFECTION 1
296 NARCOLEPSY 1
297 NASOPHARYNGITIS 1
298 NEEDLE ISSUE 1
299 NEOPLASM MALIGNANT 1
300 OCCULT BLOOD POSITIVE 1
301 OCULOMUCOCUTANEOUS SYNDROME 1
302 OEDEMA 1
303 OESOPHAGEAL CANDIDIASIS 1
304 ONYCHOMADESIS 1
305 ORAL MUCOSAL DISCOLOURATION 1
306 ORAL MUCOSAL ERUPTION 1
307 OSTEOPENIA 1
308 OVERGROWTH BACTERIAL 1
309 PAIN OF SKIN 1
310 PANCREATIC DISORDER 1
311 PANNICULITIS 1
312 PARAESTHESIA 1
313 PEMPHIGOID 1
314 PENILE BURNING SENSATION 1
315 PENILE SIZE REDUCED 1
316 PERIODONTAL DISEASE 1
317 PHARYNGEAL OEDEMA 1
318 PNEUMOTHORAX 1
319 PRESCRIBED UNDERDOSE 1
320 PRODUCT ADMINISTRATION INTERRUPTED 1
321 PRODUCT CLOSURE REMOVAL DIFFICULT 1
322 PRODUCT DOSE OMISSION ISSUE 1
323 PRODUCT PRESCRIBING ERROR 1
324 PRODUCT QUALITY ISSUE 1
325 PRODUCTIVE COUGH 1
326 PROSTATE CANCER 1
327 PROTEIN URINE 1
328 PSEUDOMONAL BACTERAEMIA 1
329 PSORIASIS 1
330 PSORIATIC ARTHROPATHY 1
331 PULMONARY EMBOLISM 1
332 PYELONEPHRITIS 1
333 RASH MACULO-PAPULAR 1
334 RASH PRURITIC 1
335 RECTAL STENOSIS 1
336 RENAL HYPERTENSION 1
337 RENAL NEOPLASM 1
338 RESPIRATORY FAILURE 1
339 RESTLESSNESS 1
340 ROOT CANAL INFECTION 1
341 SCABIES 1
342 SEGMENTED HYALINISING VASCULITIS 1
343 SEPTIC SHOCK 1
344 SEROSITIS 1
345 SEROUS RETINAL DETACHMENT 1
346 SKIN ATROPHY 1
347 SKIN CANDIDA 1
348 SKIN DISCOLOURATION 1
349 SKIN EROSION 1
350 SKIN EXFOLIATION 1
351 SKIN ULCER 1
352 SPINAL FRACTURE 1
353 SPONDYLITIS 1
354 STEVENS-JOHNSON SYNDROME 1
355 SUBARACHNOID HAEMORRHAGE 1
356 SURGERY 1
357 SWOLLEN TONGUE 1
358 SYNCOPE 1
359 TACHYPHRENIA 1
360 TASTE DISORDER 1
361 TENDERNESS 1
362 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1
363 THERAPY NON-RESPONDER 1
364 THERMAL BURN 1
365 THROAT IRRITATION 1
366 TONSILLITIS 1
367 TOXIC EPIDERMAL NECROLYSIS 1
368 TRANSIENT ISCHAEMIC ATTACK 1
369 TRAUMATIC HAEMATOMA 1
370 TRAUMATIC HAEMORRHAGE 1
371 TREATMENT FAILURE 1
372 TREATMENT NONCOMPLIANCE 1
373 TREMOR 1
374 TRICHOMONIASIS 1
375 TRICHOPHYTIC GRANULOMA 1
376 TUMOUR HAEMORRHAGE 1
377 ULCERATIVE KERATITIS 1
378 URINE ABNORMALITY 1
379 URTICARIA 1
380 VAGINAL HAEMORRHAGE 1
381 VASCULAR DEVICE INFECTION 1
382 VENTRICULAR TACHYCARDIA 1
383 VIRAL INFECTION 1
384 VOLVULUS 1
385 WEIGHT FLUCTUATION 1
386 WHITE BLOOD CELL COUNT DECREASED 1
387 WOUND 1
388 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1